Following iPolyP/TRPM8-mediated NLRP3 inflammasome activation, we sought to outline the potential role of bioactive IL-1β, highly represented in the serum of CRC-affected subjects, in the development of the disease. This evidence concerns the gene TRPM8 and colorectal carcinoma.